FondaKIDS III: A long-term retrospective cohort study of fondaparinux for treatment of venous thromboembolism in children.

This study demonstrates the stable long-term pediatric dosing of fondaparinux with similar efficacy and safety when compared to other anticoagulants. Given its advantages, fondaparinux can be considered a reasonable alternative for treatment of VTE in children.